|
1
|
Capitanio U, Bensalah K, Bex A, Boorjian
SA, Bray F, Coleman J, Gore JL, Sun M, Wood C and Russo P:
Epidemiology of renal cell carcinoma. Eur Urol. 75:74–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brugarolas J: Renal-cell
carcinoma-molecular pathways and therapies. N Engl J Med.
356:185–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li M, Wang Y, Cheng L, Niu W, Zhao G, Raju
JK, Huo J, Wu B, Yin B, Song Y and Bu R: Long non-coding RNAs in
renal cell carcinoma: A systematic review and clinical
implications. Oncotarget. 8:48424–48435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhai W, Sun Y, Guo C, Hu G, Wang M, Zheng
J, Lin W, Huang Q, Li G, Zheng J and Chang C: LncRNA-SARCC
suppresses renal cell carcinoma (RCC) progression via altering the
androgen receptor(AR)/miRNA-143-3p signals. Cell Death Differ.
24:1502–1517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang T, Wang X, Yang X, Ji J, Wang Q, Yue
X and Dong Z: Long non-coding RNA DUXAP8 enhances renal cell
carcinoma progression via downregulating miR-126. Med Sci Monit.
24:7340–7347. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Z, Yang F, Wei D, Liu B, Chen C, Bao Y,
Wu Z, Wu D, Tan H, Li J, et al: Long noncoding RNA-SRLR elicits
intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal
cell carcinoma. Oncogene. 36:1965–1977. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng F, Wang R, Zhang Y, Zhao Z, Zhou W,
Chang Z, Liang H, Zhao W, Qi L, Guo Z and Gu Y: Differential
expression analysis at the individual level reveals a lncRNA
prognostic signature for lung adenocarcinoma. Mol Cancer.
16:982017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dat Le T, Matsuo T, Yoshimaru T, Kakiuchi
S, Goto H, Hanibuchi M, Kuramoto T, Nishioka Y, Sone S and Katagiri
T: Identification of genes potentially involved in bone metastasis
by genome-wide gene expression profile analysis of non-small cell
lung cancer in mice. Int J Oncol. 40:1455–1469. 2012.PubMed/NCBI
|
|
13
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang RT, Xu M, Xu CX, Song ZG and Jin H:
Decreased expression of miR216a contributes to non-small-cell lung
cancer progression. Clin Cancer Res. 20:4705–4516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang ZZ, Luo YR, Du J, Yu Y, Yang XZ, Cui
YJ and Jin XF: MiR-296-5p inhibits cell invasion and migration of
esophageal squamous cell carcinoma by downregulating STAT3
signaling. Eur Rev Med Pharmacol Sci. 23:5206–5214. 2019.PubMed/NCBI
|
|
16
|
Han W, Wang L, Zhang L, Wang Y and Li Y:
Circular RNA circ-RAD23B promotes cell growth and invasion by
miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell
lung cancer. Biochem Biophys Res Commun. 510:462–466. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie R, Tang J, Zhu X and Jiang H:
Silencing of hsa_circ_0004771 inhibits proliferation and induces
apoptosis in breast cancer through activation of miR-653 by
targeting ZEB2 signaling pathway. Biosci Rep. 39:BSR201819192019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin CY, Chen YM, Hsu HH, Shiu CT, Kuo HC
and Chen TY: Grouper (epinephelus coioides) CXCR4 is expressed in
response to pathogens infection and early stage of development. Dev
Comp Immunol. 36:112–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao K, Yao Y, Luo X, Lin B, Huang Y, Zhou
Y, Li Z, Guo Q and Lu N: LYG-202 inhibits activation of endothelial
cells and angiogenesis through CXCL12/CXCR7 pathway in breast
cancer. Carcinogenesis. 39:588–600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Tang H, Huang J and An H:
Upregulation of CXCR7 is associated with poor prognosis of prostate
cancer. Med Sci Monit. 24:5185–5191. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bates RC, DeLeo MJ III and Mercurio AM:
The epithelial-mesenchymal transition of colon carcinoma involves
expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res.
299:315–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng Z, Cai Y, Chen H, Chen Z, Zhu D,
Zhong Q and Xie W: CXCL13/CXCR5 axis predicts poor prognosis and
promotes progression through PI3K/AKT/mTOR pathway in clear cell
renal cell carcinoma. Front Oncol. 8:6822018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guinan P, Sobin LH, Algaba F, Badellino F,
Kameyama S, MacLennan G and Novick A: TNM staging of renal cell
carcinoma: Workgroup no. 3. Union international contre le cancer
(UICC) and the American joint committee on cancer (AJCC). Cancer.
80:992–993. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sobin LH and Fleming ID: TNM
classification of malignant tumors, fifth edition (1997). Union
internationale contre le cancer and the American joint committee on
cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong JS, Wu B and Jiang B: LncRNA SNHG7
promotes the proliferation and inhibits apoptosis of renal cell
cancer cells by downregulating CDKN1A. Eur Rev Med Pharmacol Sci.
23:10241–10247. 2019.PubMed/NCBI
|
|
27
|
Yue G, Chen C, Bai L, Wang G, Huang Y,
Wang Y, Cui H and Xiao Y: Knockdown of long noncoding RNA DLEU1
suppresses the progression of renal cell carcinoma by
downregulating the Akt pathway. Mol Med Rep. 20:4551–4557.
2019.PubMed/NCBI
|
|
28
|
Yang Y, Sun DM, Yu JF, Zhang M, Yi C, Yang
R, Dan BH and Li AJ: Long noncoding RNA TUG1 promotes renal cell
carcinoma cell proliferation, migration and invasion by
downregulating microRNA196a. Mol Med Rep. 18:5791–5798.
2018.PubMed/NCBI
|
|
29
|
Shi J, Zhang D, Zhong Z and Zhang W:
lncRNA ROR promotes the progression of renal cell carcinoma through
the miR-206/VEGF axis. Mol Med Rep. 20:3782–3792. 2019.PubMed/NCBI
|
|
30
|
Yu C and Zhang Y: Characterization of the
prognostic values of CXCR family in gastric cancer. Cytokine.
123:1547852019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saintigny P, Massarelli E, Lin S, Ahn YH,
Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, et al: CXCR2
expression in tumor cells is a poor prognostic factor and promotes
invasion and metastasis in lung adenocarcinoma. Cancer Res.
73:571–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun KH, Sun GH, Wu YC, Ko BJ, Hsu HT and
Wu ST: TNF-α augments CXCR2 and CXCR3 to promote progression of
renal cell carcinoma. J Cell Mol Med. 20:2020–2028. 2016.
View Article : Google Scholar : PubMed/NCBI
|
